Indianapolis-based insurer Anthem Inc. said it will set up its own pharmacy benefits management unit, signaling a final break with Express Scripts Holding Co. after the health insurer accused Express of overcharging it by billions of dollars.
Senators in both political parties say they’ve reached agreement on fixes to stabilize Obamacare just two weeks before Americans start signing up for 2018 coverage.
Two leading senators said Tuesday they have the “basic outlines” of a bipartisan agreement to resume federal payments to health insurers that President Donald Trump has blocked.
Indianapolis-based Anthem Inc. declined to say Friday whether it would retreat even further from Obamacare than it already has in recent months.
Shares of publicly traded hospital chains including Tenet Healthcare Corp. slumped on Friday, as did insurers such as Centene Corp. and Anthem Inc.
Frustrated over setbacks in Congress, President Donald Trump wielded his rule-making power Thursday to launch an executive order that might get him closer to his goal of repealing and replacing Obamacare.
The deal comes as Express Scripts faces challenges on a number of fronts, including the possible loss of its largest customer, Indianapolis-based health-insurance giant Anthem Inc.
The university will hire 10 faculty members and team with the state and major health systems on what it calls a comprehensive plan to understand and deal with addictions, which are costing Indiana more than $1 billion a year.
California has passed a law requiring pharmaceutical companies to explain their price increases, escalating the state-by-state battle between lawmakers trying to bring more transparency to the industry’s practices and drugmakers that oppose the efforts.
The White House is finalizing an executive order that would expand health plans offered by associations to allow individuals to pool together and buy insurance outside their states.
Harry Zhang pleaded guilty to two felonies this month after charged with illegally obtaining prescriptions from Canada and Germany and reselling them in China.
Thirty-four new drugs—treating everything from cancer to rare genetic diseases—have been approved so far this year. That’s on pace to nearly double last year’s approvals.
High-deductible health plans are booming in popularity, but, in an effort to save money, too many people are skipping preventive care even though such visits are covered 100 percent.
The city of Indianapolis plans to file a “robust lawsuit” against several drug companies, Mayor Joe Hogsett announced Thursday morning.
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
From January to July, the agency sent 265 warning letters to companies, notifying them of what it alleged to be serious violations of federal rules. That’s the lowest tally for the first seven months of any year since 2008.
Castlight Health, a benefits platform, estimates that opioid abusers cost employers nearly twice as much in health-care expenses as their clean co-workers—an extra $8,600 a year.
Unfortunately, what started as a solution for pain turned into a crisis that is killing people.
A sampling of panelists’ conversation at IBJ’s Sept. 21 Health Care & Benefits Power Breakfast.
